NICE recommends updacitinib to treat moderate rheumatoid arthritis
NICE has recommended a combination of updacitinib and methotrexate as an option to treat moderate active rheumatoid arthritis in adults, who responded inadequately to...
This site is intended for Healthcare Professionals only.
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc
This site is intended for Healthcare Professionals only.